Metraipolis › archive › dc_93a06c2ade82

Cost-effectiveness of testing biofluid biomarkers to diagnose Alzheimer's disease: a systematic review — Europe PMC PMID:41385058

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41385058
DOI
10.1007/s10198-[numero omesso]-1
License (as archived)
solo-consultazione
Archived
2026-11-07T17:10:03.081Z
SHA-256 of the archived text
68a96112fb30c5770a4615a075a3b30e2fb7fbeb527faffbb0b89f2adbc2c37f
Stable URL of this page
https://metraipolis.com/documento/dc_93a06c2ade82

How to cite

Cost-effectiveness of testing biofluid biomarkers to diagnose Alzheimer's disease: a systematic review — Europe PMC PMID:41385058 — Europe PMC (en), https://europepmc.org/article/MED/41385058 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_93a06c2ade82 (Metraipolis archive dc_93a06c2ade82, sha256 68a96112fb30c5770a4615a075a3b30e2fb7fbeb527faffbb0b89f2adbc2c37f)
BibTeX
@misc{dc93a06c2ade82,
  title = {Cost-effectiveness of testing biofluid biomarkers to diagnose Alzheimer's disease: a systematic review — Europe PMC PMID:41385058},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41385058},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_93a06c2ade82; sha256 68a96112fb30c5770a4615a075a3b30e2fb7fbeb527faffbb0b89f2adbc2c37f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41385058. Agents can read the archived copy with the MCP tool read_document.